Elucidating polypharmacological mechanisms of polyphenols by gene module profile analysis

International Journal of Molecular Sciences

Volumn 15, Issue 7, 2014, Pages 11245-11254

  Li, Bin ^a   Xiong, Min ^a   Zhang, Hong Yu ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Biclustering analysis; Polypharmacology; Polyphenol; Target

Indexed keywords

APOMORPHINE; CISAPRIDE; DAUNORUBICIN; DIETHYLSTILBESTROL; DIPYRIDAMOLE; DYDROGESTERONE; ESTRADIOL; FINASTERIDE; FLUPHENAZINE; FLUTICASONE; GENISTEIN; ILOPROST; LETROZOLE; MERCAPTOPURINE; METIXENE; NICLOSAMIDE; PHYTOESTROGEN; POLYPHENOL; PREDNISONE; QUERCETIN; RALOXIFENE; RESCINNAMINE; RESERPINE; SULINDAC SULFIDE; TAMOXIFEN; TERFENADINE; TOCAINIDE; TOLAZOLINE; TRIFLUOPERAZINE; UNINDEXED DRUG;

ARTICLE; CELL CYCLE; CELL MOTION; CLUSTER ANALYSIS; CONNECTOME; GENE EXPRESSION; MATHEMATICAL PARAMETERS; MICROARRAY ANALYSIS; OXIDATIVE PHOSPHORYLATION; POLYPHARMACOLOGY; PROTEIN TRANSPORT; PURINE METABOLISM; PYRIMIDINE METABOLISM; RNA PROCESSING; RNA TRANSLATION; ALGORITHM; CHEMISTRY; DRUG EFFECTS; GENE REGULATORY NETWORK; HUMAN;

ALGORITHMS; GENE REGULATORY NETWORKS; HUMANS; POLYPHENOLS;

EID: 84903373324     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150711245     Document Type: Article

References (51)

1. Halliwell, B.; Gutteridge, J. Free Radicals in Biology and Medicine; Oxford University Press: New York, NY, USA, 2007.
2. Rice-Evans, C. A.; Miller, N. J.; Paganga, G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 1996, 20, 933-956.
3. Zhang, H. Y. Structure-activity relationships and rational design strategies for radical-scavenging antioxidants. Curr. Comput. Aided Drug Des. 2005, 1, 257-273.
4. Fernández-Arroyo, S.; Herranz-López, M.; Beltrán-Debón, R.; Borrás-Linares, I.; Barrajón-Catalán, E.; Joven, J.; Fernández-Gutiérrez, A.; Segura-Carretero, A.; Micol, V. Bioavailability study of a polyphenol-enriched extract from Hibiscus Sabdariffa in rats and associated antioxidant status. Mol. Nutr. Food Res. 2012, 56, 1590-1595.
5. Melton, L. The antioxidant myth: a medical fairy tale. New Sci. 2006, 2563, 40-43.
6. Pun, P. B.; Gruber, J.; Tang, S. Y.; Schaffer, S.; Ong, R. L.; Fong, S.; Ng, L. F.; Cheah, I.; Halliwell, B. Ageing in nematodes: Do antioxidants extend lifespan in Caenorhabditis elegans? Biogerontology 2010, 11, 17-30.
7. Stanner, S. A.; Hughes, J.; Kelly, C. N.; Buttriss, J. A review of the epidemiological evidence for the "antioxidant hypothesis". Public Health Nutr. 2004, 7, 407-422.
8. Hollman, P. C.; Cassidy, A.; Comte, B.; Heinonen, M.; Richelle, M.; Richling, E.; Serafini, M.; Scalbert, A.; Sies, H.; Vidry, S. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J. Nutr. 2011, 141, 989S-1009S.
9. Halliwell, B. Free radicals and antioxidants-Quo vadis? Trends Pharmacol. Sci. 2011, 32, 125-130.
10. Halliwell, B.; Rafter, J.; Jenner, A. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am. J. Clin. Nutr. 2005, 81, 268S-276S.
11. Zhang, H. Y.; Chen, L. L.; Li, X. J.; Zhang, J. Evolutionary inspirations for drug discovery. Trends Pharmacol. Sci. 2010, 31, 443-448.
12. Ji, H. F.; Li, X. J.; Zhang, H. Y. Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia? EMBO Rep. 2009, 10, 194-200.
13. Middleton, E.; Kandaswami, C.; Theoharides, T. C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52, 673-751.
14. Yue, R.; Shan, L.; Yang, X.; Zhang, W. Approaches to target profiling of natural products. Curr. Med. Chem. 2012, 19, 3841-3855.
15. Lamb, J.; Crawford, E. D.; Peck, D.; Modell, J. W.; Blat, I. C.; Wrobel, M. J.; Lerner, J.; Brunet, J. P.; Subramanian, A.; Ross, K. N.; et al. The Connectivity Map: Using gene-expression signatures to connect small molecules, genes, and disease. Science 2006, 313, 1929-1935.
16. Iorio, F.; Bosotti, R.; Scacheri, E.; Belcastro, V.; Mithbaokar, P.; Ferriero, R.; Murino, L.; Tagliaferri, R.; Brunetti-Pierri, N.; Isacchi, A.; et al. Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc. Natl. Acad. Sci. USA 2010, 107, 14621-14626.
17. Qu, X. A.; Rajpal, D. K. Applications of Connectivity Map in drug discovery and development. Drug Discov. Today 2012, 17, 1289-1298.
18. Hochreiter, S.; Bodenhofer, U.; Heusel, M.; Mayr, A.; Mitterecker, A.; Kasim, A.; Khamiakova, T.; van Sanden, S.; Lin, D.; Talloen, W.; et al. A. FABIA: factor analysis for bicluster acquisition. Bioinformatics 2010, 26, 1520-1527.
19. Xiong, M.; Li, B.; Zhu, Q.; Wang, Y. X.; Zhang, H. Y. Identification of transcription factors for drug-associated gene modules and biomedical implications. Bioinformatics 2013, 30, 305-309.
20. Wishart, D. S. DrugBank and its relevance to pharmacogenomics. Pharmacogenomics 2008, 9, 1155-1162.
21. Zhu, F.; Shi, Z.; Qin, C.; Tao, L.; Liu, X.; Xu, F.; Zhang, L.; Song, Y.; Zhang, J.; Han, B.; et al. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012, 40, D1128-D1136.
22. Stelzer, G.; Inger, A.; Olender, T.; Iny-Stein, T.; Dalah, I.; Harel, A.; Safran, M.; Lancet, D. GeneDecks: Paralog hunting and gene-set distillation with GeneCards annotation. OMICS 2009, 13, 477-487.
23. Chen, Z. Y.; Peng, C.; Jiao, R.; Wong, Y. M.; Yang, N.; Huang, Y. Anti-hypertensive nutraceuticals and functional foods. J. Agric. Food Chem. 2009, 57, 4485-4499.
24. Wang, J.; Zhang, W.; Sun, L.; Yu, H.; Ni, Q. X.; Risch, H. A.; Gao, Y. T. Green tea drinking and risk of pancreatic cancer: A large-scale, population-based case-control study in urban Shanghai. Cancer Epidemiol. 2012, 36, e354-e358.
25. Kurahashi, N.; Sasazuki, S.; Iwasaki, M.; Inoue, M.; Tsugane, S.; Grp, J. S. Green tea consumption and prostate cancer risk in Japanese men: A prospective study. Am. J. Epidemiol. 2008, 167, 71-77.
26. Trichopoulou, A.; Lagiou, P.; Kuper, H.; Trichopoulos, D. Cancer and Mediterranean dietary traditions. Cancer Epidemiol. Biomark. Prev. 2000, 9, 869-873.
27. Erlund, I. Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, and epidemiology. Nutr. Res. 2004, 24, 851-874.
28. Bhat, K. P.; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol. Ann. N. Y. Acad. Sci. 2002, 957, 210-229.
29. Beretz, A.; Anton, R.; Stoclet, J. C. Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase. Experientia 1978, 34, 1054-1055.
30. Kuiper, G. G.; Lemmen, J. G.; Carlsson, B.; Corton, J. C.; Safe, S. H.; van der Saag, P. T.; van der Burg, B.; Gustafsson, J. A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139, 4252-4263.
31. Goodin, M. G.; Fertuck, K. C.; Zacharewski, T. R.; Rosengren, R. J. Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro. Toxicol. Sci. 2002, 69, 354-361.
32. Baur, J. A.; Mai, A. Revelations into resveratrol's mechanism. Nat. Med. 2012, 18, 500-501.
33. Yan, G. R.; Xiao, C. L.; He, G. W.; Yin, X. F.; Chen, N. P.; Cao, Y.; He, Q. Y. Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways. Proteomics 2010, 10, 976-986.
34. Lin, M. Q.; den Dulk-Ras, A.; Hooykaas, P. J. J.; Rikihisa, Y. Anaplasma phagocytophilum AnkA secreted by type IV secretion system is tyrosine phosphorylated by Abl-1 to facilitate infection. Cell Microbiol. 2007, 9, 2644-2657.
35. Packer, A. I.; Hsu, Y. C.; Besmer, P.; Bachvarova, R. F. The ligand of the c-kit receptor promotes oocyte growth. Dev. Biol. 1994, 161, 194-205.
36. Rickard, D. J.; Monroe, D. G.; Ruesink, T. J.; Khosla, S.; Riggs, B. L.; Spelsberg, T. C. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta. J. Cell Biochem. 2003, 89, 633-646.
37. Hermenegildo, C.; Oviedo, P. J.; Garcia-Perez, M. A.; Tarin, J. J.; Cano, A. Effects of phytoestrogens genistein and daidzein on prostacyclin production by human endothelial cells. J. Pharmacol. Exp. Ther. 2005, 315, 722-728.
38. Shih, C.-H.; Lin, L.-H.; Lai, Y.-H.; Lai, C.-Y.; Han, C.-Y.; Chen, C.-M.; Ko, W.-C. Genistein, a competitive PDE1-4 inhibitor, may bind on high-affinity rolipram binding sites of brain cell membranes and then induce gastrointestinal adverse effects. Eur. J. Pharmacol. 2010, 643, 113-120.
39. Nishizaki, Y.; Ishimoto, Y.; Hotta, Y.; Hosoda, A.; Yoshikawa, H.; Akamatsu, M.; Tamura, H. Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay. Bioorg. Med. Chem. Lett. 2009, 19, 4706-4710.
40. Ye, L.; Su, Z. J.; Ge, R. S. Inhibitors of testosterone biosynthetic and metabolic activation enzymes. Molecules 2011, 16, 9983-10001.
41. Maggiolini, M.; Bonofiglio, D.; Marsico, S.; Panno, M. L.; Cenni, B.; Picard, D.; Ando, S. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol. Pharmacol. 2001, 60, 595-602.
42. Lines, T. C.; Ono, M. FRS 1000, an extract of red onion peel, strongly inhibits phosphodiesterase 5A (PDE 5A). Phytomedicine 2006, 13, 236-239.
43. Gaulton, A.; Bellis, L. J.; Bento, A. P.; Chambers, J.; Davies, M.; Hersey, A.; Light, Y.; McGlinchey, S.; Michalovich, D.; Al-Lazikani, B.; et al. ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2012, 40, D1100-D1107.
44. Wallace, C. H. R.; Baczko, I.; Jones, L.; Fercho, M.; Light, P. E. Inhibition of cardiac voltage-gated sodium channels by grape polyphenols. Br. J. Pharmacol. 2006, 149, 657-665.
45. Granados-Soto, V.; Arguelles, C. F.; Ortiz, M. I. The peripheral antinociceptive with activation of effect of resveratrol is associated potassium channels. Neuropharmacology 2002, 43, 917-923.
46. Park, S. J.; Ahmad, F.; Philp, A.; Baar, K.; Williams, T.; Luo, H.; Ke, H.; Rehmann, H.; Taussig, R.; Brown, A. L.; et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012, 148, 421-433.
47. Melzig, M. F.; Escher, F. Induction of neutral endopeptidase and anglotensin-converting enzyme activity of SK-N-SH cells in vitro by quercetin and resveratrol. Pharmazie 2002, 57, 556-558.
48. Davis, A. P.; King, B. L.; Mockus, S.; Murphy, C. G.; Saraceni-Richards, C.; Rosenstein, M.; Wiegers, T.; Mattingly, C. J. The comparative toxicogenomics database: Update 2011. Nucleic Acids Res. 2011, 39, D1067-D1072.
49. Damianaki, A.; Bakogeorgou, E.; Kampa, M.; Notas, G.; Hatzoglou, A.; Panagiotou, S.; Gemetzi, C.; Kouroumalis, E.; Martin, P.-M.; Castanas, E. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J. Cell Biochem. 2000, 78, 429-441.
50. Katavic, P. L.; Lamb, K.; Navarro, H.; Prisinzano, T. E. Flavonoids as opioid receptor ligands: Identification and preliminary structure-activity relationships. J. Nat. Prod. 2007, 70, 1278-1282.
51. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B. 1995, 57, 289-300.